148 related articles for article (PubMed ID: 9343502)
1. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease.
Bandmann O; Vaughan J; Holmans P; Marsden CD; Wood NW
Lancet; 1997 Oct; 350(9085):1136-9. PubMed ID: 9343502
[TBL] [Abstract][Full Text] [Related]
2. Detailed genotyping demonstrates association between the slow acetylator genotype for N-acetyltransferase 2 (NAT2) and familial Parkinson's disease.
Bandmann O; Vaughan JR; Holmans P; Marsden CD; Wood NW
Mov Disord; 2000 Jan; 15(1):30-5. PubMed ID: 10634239
[TBL] [Abstract][Full Text] [Related]
3. Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese.
Chan DK; Lam MK; Wong R; Hung WT; Wilcken DE
Neurology; 2003 Mar; 60(6):1002-5. PubMed ID: 12654968
[TBL] [Abstract][Full Text] [Related]
4. N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population.
Bialecka M; Gawronska-Szklarz B; Drozdzik M; Honczarenko K; Stankiewicz J
Eur J Clin Pharmacol; 2002 Feb; 57(12):857-62. PubMed ID: 11936704
[TBL] [Abstract][Full Text] [Related]
5. Association of slow acetylator genotype of N-acetyltransferase 2 with Parkinson's disease in south Indian population.
Pandi S; Chinniah R; Sevak V; Ravi PM; Vijayan M; Vellaiappan NA; Karuppiah B
Neurosci Lett; 2020 Sep; 735():135260. PubMed ID: 32682841
[TBL] [Abstract][Full Text] [Related]
6. N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease.
Borlak J; Reamon-Buettner SM
BMC Med Genet; 2006 Mar; 7():30. PubMed ID: 16571112
[TBL] [Abstract][Full Text] [Related]
7. Acetylator genotype and Parkinson's disease.
Nicholl DJ; Bennett P
Lancet; 1998 Jan; 351(9096):141-2. PubMed ID: 9439519
[No Abstract] [Full Text] [Related]
8. Acetylator genotype and Parkinson's disease.
Paolini M
Lancet; 1998 Jan; 351(9096):141; author reply 142. PubMed ID: 9439518
[No Abstract] [Full Text] [Related]
9. Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease.
Singh M; Khanna VK; Shukla R; Parmar D
Dis Markers; 2010; 28(2):87-93. PubMed ID: 20364044
[TBL] [Abstract][Full Text] [Related]
10. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
11. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
[TBL] [Abstract][Full Text] [Related]
12. Toxins, genetics, and Parkinson's disease: the role of N-acetyltransferase 2.
Bandmann O; Vaughan J; Holmans PA; Marsden CD; Wood NW
Adv Neurol; 1999; 80():199-204. PubMed ID: 10410722
[No Abstract] [Full Text] [Related]
13. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
14. [The role of N-acetyltransferase polymorphism in the pathogenesis of Parkinson's disease].
Kłodowska-Duda GA; Opala GM; Ochudło SG
Neurol Neurochir Pol; 2003; 37(5):1095-101. PubMed ID: 15174255
[TBL] [Abstract][Full Text] [Related]
15. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.
van der Walt JM; Martin ER; Scott WK; Zhang F; Nance MA; Watts RL; Hubble JP; Haines JL; Koller WC; Lyons K; Pahwa R; Stern MB; Colcher A; Hiner BC; Jankovic J; Ondo WG; Allen FH; Goetz CG; Small GW; Mastaglia F; Roses AD; Stajich JM; Booze MW; Fujiwara K; Gibson RA; Middleton LT; Scott BL; Pericak-Vance MA; Vance JM
Neurology; 2003 Apr; 60(7):1189-91. PubMed ID: 12682333
[TBL] [Abstract][Full Text] [Related]
17. Association of N-acetyl transferase 2 gene polymorphism and slow acetylator phenotype with young onset and late onset Parkinson's disease among Indians.
Chaudhary S; Behari M; Dihana M; Swaminath PV; Govindappa ST; Jayaram S; Singh S; Muthane UB; Juyal RC; B K T
Pharmacogenet Genomics; 2005 Oct; 15(10):731-5. PubMed ID: 16141799
[TBL] [Abstract][Full Text] [Related]
18. Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease.
Maraganore DM; Farrer MJ; Hardy JA; McDonnell SK; Schaid DJ; Rocca WA
Mov Disord; 2000 Jul; 15(4):714-9. PubMed ID: 10928584
[TBL] [Abstract][Full Text] [Related]
19. Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease.
Agúndez JA; Jiménez-Jiménez FJ; Luengo A; Molina JA; Ortí-Pareja M; Vázquez A; Ramos F; Duarte J; Coria F; Ladero JM; Alvarez-Cermeño JC; Benítez J
Neurology; 1998 Dec; 51(6):1587-92. PubMed ID: 9855506
[TBL] [Abstract][Full Text] [Related]
20. The role of NAT2 gene polymorphism in aetiology of the most frequent neurodegenerative diseases with dementia.
Gołab-Janowska M; Honczarenko K; Gawrońska-Szklarz B; Potemkowski A
Neurol Neurochir Pol; 2007; 41(5):388-94. PubMed ID: 18033638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
